Prevention and Control of HIV/AIDS in China: Lessons from the Past Three Decades
Since the identification of the first HIV case in 1985, China has navigated a complex and evolving epidemic characterized by shifting transmission dynamics, diverse HIV-1 subtypes, and targeted public health responses. Over nearly four decades, the country transformed its approach from crisis management to a structured national strategy, achieving significant milestones in curbing transmission routes, expanding treatment access, and mobilizing societal engagement. This article examines China’s journey in HIV/AIDS control, highlighting key policies, interventions, and challenges that shaped its epidemiological trajectory.
Evolution of the Epidemic
The HIV/AIDS epidemic in China unfolded in three distinct phases. Initially sporadic cases from overseas (1985–1988) were followed by localized outbreaks among injection drug users (IDUs) in Yunnan Province (1989–1994), near the drug-trafficking hub of the Golden Triangle. By 1995, the epidemic expanded nationwide, driven by unsafe blood collection practices in rural provinces like Henan and Anhui, which infected tens of thousands through contaminated plasma transfusions. Sexual transmission—initially a minor contributor—surged in the 2000s, becoming the dominant route by 2019, accounting for over 95% of new infections. Heterosexual transmission rose from 30.6% of cases in 2006 to 66.5% in 2020, while homosexual transmission among men who have sex with men (MSM) increased from 2.5% to 33.4% in the same period. By 2020, eight out of every 100 MSM in China were living with HIV.
Virologically, China hosts one of the world’s most diverse HIV-1 landscapes, with six subtypes, 20 circulating recombinant forms (CRFs), and 117 unique recombinant forms (URFs). Early outbreaks introduced subtypes B, C, and CRF01_AE, but localized recombination generated new strains like CRF07_BC and CRF08_BC among IDUs and CRF55_01B and CRF59_01B among MSM. These recombinant viruses underscore high-risk populations’ role as “incubators” for viral diversification.
National Strategies and Achievements
Political Commitment and Governance
China’s centralized governance model enabled rapid, large-scale interventions. In 2004, the State Council AIDS Working Committee was established, coordinating 34 ministries and provincial leaders under the direct oversight of the Vice Premier. Annual HIV/AIDS funding grew at 10.1% from 1995 to 2015, reaching 6.96 billion RMB (1.14 billion USD) in 2017. The Comprehensive AIDS Response (CARES) Program, launched in 2003, piloted integrated prevention and treatment models across 309 counties, covering 170 million people by 2013. CARES emphasized multi-sector collaboration, public education, and community-based interventions, achieving 86% awareness in rural areas and 91% in urban populations by 2008.
Curtailing Drug Use and Blood Transmission
To address IDU-driven outbreaks, China implemented methadone maintenance therapy (MMT) and needle-exchange programs. By 2016, 161,975 IDUs received MMT, reducing HIV incidence from 0.95 to 0.03 per 100 person-years between 2006 and 2017. The 1998 Blood Donation Act abolished commercial plasma stations and mandated nucleic acid testing (NAT) for blood donations nationwide by 2014, slashing the HIV detection window by 50%. These measures averted an estimated 98,232–211,200 infections and virtually eliminated transfusion-related HIV by 2020.
Combatting Sexual Transmission
China’s response to sexual transmission involved condom promotion, behavioral interventions, and targeted testing. Between 2008 and 2014, monthly outreach covered 440,000 female sex workers (FSWs) and 252,000 MSM, raising condom use to 70.7% among FSWs and 46.2% among MSM. In 2020, pre-exposure prophylaxis (PrEP) with Truvada® and national post-exposure prophylaxis (PEP) guidelines were introduced. Despite these efforts, MSM incidence remains high at 5.5 per 100 person-years, driven by stigma, low testing rates (47%), and bisexual behaviors bridging transmission to female partners.
Preventing Mother-to-Child Transmission (PMTCT)
China’s PMTCT program, initiated in 2003, provides free antenatal HIV testing and antiretroviral prophylaxis. Mother-to-child transmission rates fell from 7.1% in 2012 to 4.9% in 2017, nearing the global elimination threshold of 2%. Yunnan Province achieved a 2.83% transmission rate in 2017, demonstrating the impact of scalable, state-funded healthcare interventions.
Diagnostic and Treatment Advances
A robust testing network—98% of counties had screening labs by 2020—enabled 200 million annual HIV tests. Hospital-based testing diagnosed 52.2% of cases, while voluntary counseling and testing (VCT) sites identified 28.9%. The National Free Antiretroviral Treatment Program, launched in 2003, achieved 80% coverage and 91% viral suppression by 2017, despite per-patient costs of 706 USD versus 9,489 USD in the U.S. Standardized guidelines, centralized drug procurement, and a CDC-hospital-community management model contributed to these outcomes.
Societal Mobilization and Global Collaboration
Public awareness campaigns, school-based sex education, and celebrity advocacy reduced stigma and discrimination. Over 789 community-based organizations (CBOs) engaged high-risk groups, while ambassadors like Peng Liyuan, China’s First Lady and WHO Goodwill Ambassador, amplified prevention messaging. International partnerships, including the Global Fund (324 million USD, 2003–2013) and the Gates Foundation (50 million USD), supported drug procurement, CBO capacity-building, and surveillance systems.
Persistent Challenges and Future Directions
Controlling Sexual Transmission
Synthetic drug use among youth, rising non-marital heterosexual contact, and online dating platforms (13.4% of youths) fuel HIV spread. Among MSM, 34% of infections are undiagnosed, and late diagnosis remains common, with 34% identified at advanced disease stages. Recommendations include:
- Expanding PrEP and HIV self-testing, leveraging online platforms for outreach.
- Enforcing partner notification policies and integrating sexual health into school curricula.
- Addressing bisexual MSM behaviors, where 28.1% use condoms inconsistently with female partners.
Enhancing Detection and Treatment
An estimated 30% of infections remain undetected. Simplified testing protocols (e.g., “One4All” strategy combining rapid diagnosis and immediate ART) could reduce losses to follow-up. Drug resistance, though currently low (3.6% vs. 8.4% in high-income countries), threatens long-term efficacy, particularly with limited third-line drug options.
Conclusion
China’s HIV/AIDS response exemplifies the synergy of political will, societal mobilization, and global solidarity. By prioritizing evidence-based policies, scaling interventions, and adapting to epidemiological shifts, China averted a generalized epidemic despite initial predictions of 10 million infections by 2010. Future success hinges on curbing sexual transmission, closing detection gaps, and sustaining treatment efficacy. As China strives toward the UNAIDS 95-95-95 targets, its experiences offer valuable lessons for global health governance in balancing urgency, equity, and innovation.
doi.org/10.1097/CM9.0000000000001842
Was this helpful?
0 / 0